The American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago, (USA)
Pivotal, represented by members of our Senior Management, will attend, as usual, the American Society...
New collaboration aims to further accelerate the delivery of novel treatments for difficult-to-treat cancers
Pivotal has enrolled the first patients in a recently awarded new phase II trial in...
ESMO 2019 annual congress will take place in Barcelona, from the 27th of September to 1st October
On Tuesday, October 23rd, the European Society for Medical Oncology Congress (<a...
Pivotal and ESMO working on different levels to improve prevention, diagnosis, treatment, and palliative care of cancer patients through clinical research
Pivotal, the Madrid-based, European-wide Clinical Research Organization (CRO), is...
New collaboration aims to further accelerate the delivery of investigational treatments for asthma
Pivotal and Palobiofarma announced today a new strategic collaboration to expand access of patients to novel...
Collaboration will further assess novel investigational cancer treatments combined with standard chemotherapy
PIVOTAL and APRO have announced today a close collaboration in 3 different oncology clinical trials to test...
Pivotal has been selected as one of the few firms that attracted recognition from the Pharma IQ network as a “RISING STAR"
We´re delighted to bring to...
New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers in Europe
Sarah Cannon Development Innovations announced today a new strategic collaboration with Pivotal...
All fields are required